Stack Lab
Compare compound mechanisms, evidence quality, related research topics, receptor considerations, and live COA-verified prices. Add 1–5 compounds.
Research signals
- ATX-304EmergingBreakout
- Triple AgonistRich researchBreakout
- Dual Incretin AgonistRich researchBreakout
- MOTS-cRich researchBreakout
- NAD+Rich researchBreakout
Receptor Compatibility
Redundancy, true conflicts, and dangerous additive effects
Receptor conflicts not yet analyzed for this stack
Evidence review
A structured review of the evidence for this stack
Sign in to build a structured evidence review for ATX-304 + Triple Agonist + Dual Incretin Agonist + MOTS-c + NAD+ — mechanisms, evidence, endpoints, and limitations grounded in documented research.
Community data
Aggregate research activity for this selection
No researchers have logged this exact combination yet — yours could be the first.
Researchers are also adding
Pricing snapshot
Best price for each compound today
- 2 panels$44.09 · 1250mg
- 8 panels$21 · 10mg$2.10/mg
- 4 panels$17.10 · 10mg$1.71/mg
- 8 panels$18 · 10mg$1.80/mg
- 8 panels$22.50 · 500mg$0.04/mg
Same “From” price shown on each compound's page (after discounts). Panels = COA assays tested. Tap “Compare all vendors” for the full breakdown.
For research and informational use only. VialTalk does not provide medical advice or dosing guidance. Community data reflects self-reported public research journals.